S John Liu

S John Liu

University of California, San Francisco

H-index: 22

North America-United States

About S John Liu

S John Liu, With an exceptional h-index of 22 and a recent h-index of 21 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Genomics, Cancer, non-coding RNA, radiation oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance

Epigenetic reprogramming shapes the cellular landscape of schwannoma

SPCR-10 CANCER CO-ROUNDS: A NOVEL INPATIENT MULTIDISCIPLINARY ONCOLOGY ROUNDING MODEL

Compositions and methods of treating glioma

Cancer co-rounds: A novel inpatient multidisciplinary oncology rounding model.

Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution

MerlinS13 phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features

CRISPRi screens identify the lncRNA, LOUP, as a multifunctional locus regulating macrophage differentiation epigenetically and inflammatory signaling through a short, encoded …

S John Liu Information

University

Position

___

Citations(all)

6073

Citations(since 2020)

4687

Cited By

3115

hIndex(all)

22

hIndex(since 2020)

21

i10Index(all)

26

i10Index(since 2020)

26

Email

University Profile Page

Google Scholar

S John Liu Skills & Research Interests

Genomics

Cancer

non-coding RNA

radiation oncology

Top articles of S John Liu

Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance

Nature communications

2024/1/12

SPCR-10 CANCER CO-ROUNDS: A NOVEL INPATIENT MULTIDISCIPLINARY ONCOLOGY ROUNDING MODEL

Neuro-Oncology Advances

2023/8/1

S John Liu
S John Liu

H-Index: 17

Compositions and methods of treating glioma

2023/6/22

Cancer co-rounds: A novel inpatient multidisciplinary oncology rounding model.

2023/6/1

Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution

Research Square

2023/5/15

MerlinS13 phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features

Research Square

2023/3/14

CRISPRi screens identify the lncRNA, LOUP, as a multifunctional locus regulating macrophage differentiation epigenetically and inflammatory signaling through a short, encoded …

bioRxiv

2023

S John Liu
S John Liu

H-Index: 17

Susan Carpenter
Susan Carpenter

H-Index: 22

Provider Perceptions of a Novel Inpatient Co-Rounding Model Integrating Medical Oncology, Neuro-Oncology, and Radiation Oncology for the Care of Patients with Advanced Cancer

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Adjuvant Chemoradiotherapy within One Year of Resection for Molecularly Defined Astrocytoma

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

CRISPR-Based Epigenome Editing and Genome Wide Screening Define Mediators of Chemotherapy Response in Glioblastoma

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastoma

bioRxiv

2023/9/3

S John Liu
S John Liu

H-Index: 17

David Wu
David Wu

H-Index: 20

Dual genome-wide coding and lncRNA screens in neural induction of induced pluripotent stem cells

Cell genomics

2022/11/9

CSIG-37. MERLIN S13 DEPHOSPHORYLATION DRIVES MENINGIOMA WNT SIGNALLING AND CELL PROLIFERATION

Neuro-Oncology

2022/11

S John Liu
S John Liu

H-Index: 17

Harish Vasudevan
Harish Vasudevan

H-Index: 9

TMIC-36. REPROGRAMMING THE GLIOBLASTOMA IMMUNE MICROENVIRONMENT WITH CONVECTION ENHANCED GENE THERAPY REVEALS INTRATUMOR IL6 DRIVES GLIOBLASTOMA IMMUNOSUPPRESSION AND GROWTH

Neuro-Oncology

2022/11/1

TMIC-43. HEDGEHOG LIGANDS FROM GLIOBLASTOMA CELLS INDUCE ASTROCYTES INHIBITION OF CANCER STEM CELLS

Neuro-Oncology

2022/11/1

EPCO-01. EPIGENETIC REPROGRAMMING SHAPES THE MOLECULAR AND CELLULAR LANDSCAPE OF SCHWANNOMA

Neuro-Oncology

2022/11/1

DDDR-06. NEUROFIBROMATOSIS TUMOR SUPPRESSORS COOPERATIVELY DRIVE TUMOR DE-DIFFERENTIATION AND MEK INHIBITOR RESISTANCE IN PERIPHERAL NERVOUS SYSTEM TUMORS

Neuro-Oncology

2022/11/1

PATH-37. SPATIAL GENE EXPRESSION PROGRAMS AND PROTEIN SIGNALING MECHANISMS DRIVE MENINGIOMA EVOLUTION AND THERAPEUTIC VULNERABILITY

Neuro-Oncology

2022/11/1

Timing of Adjuvant Radiotherapy and Survival Analysis for Molecularly Defined Low Grade Glioma

International Journal of Radiation Oncology, Biology, Physics

2022/11/1

See List of Professors in S John Liu University(University of California, San Francisco)

Co-Authors

academic-engine